Aidspan publishes new issue of 'Global Fund Observer'

NewsGuard 100/100 Score
Feb 26 2013

Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, on Tuesday published Issue 210 of its "Global Fund Observer." The issue contains an article on "recent developments concerning grants to Mali" from the Global Fund; an article examining "reports on audits conducted on Global Fund grants in Central African Republic (CAR), Viet Nam and Tajikistan," issued by the Office of the Inspector General; and an article discussing a farewell letter from former Fund General Manager Gabriel Jaramillo, among others (2/25).

http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Posted in: Disease/Infection News | Healthcare News

Tags: , , , , ,

Comments (0)

Suggested Reading

Study reveals lasting lung damage in tuberculosis survivors
WHO releases an investment case for TB screening and preventive treatment
The path to a better tuberculosis vaccine runs through Montana
New malaria vaccine strain shows promise in preclinical trials
Enzymatic cocktail emerges as new hope against mycobacterial infections
Revvity unveils a new era of automated tuberculosis testing
Pioneering study launched to examine how the immune system responds to repeated malaria infections
Innovative malaria prodrug targets liver, enhances efficacy while reducing toxicity, preclinical studies show

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
New study finds interferon-γ release assays more effective than skin tests in predicting tuberculosis